Numerous studies have suggested that procyanidins may improve AD-related brainneuropathology by preventing the production of toxic peptides such as amyloidprecursor protein (APP) processing, amyloid-protein build-up (40), and tauopathy (41,42). This evidence concerns the gene APP and Alzheimer disease.